NCT06389955View on ClinicalTrials.gov

Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

August 24, 2023

Conditions
Healthy
Interventions
DRUG

TP 3654

TP 3654 is an investigational orally delivered drug

Trial Locations (1)

07094

Frontage Investigative Site, Secaucus

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT06389955 - Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654 | Biotech Hunter | Biotech Hunter